28 September 2017
New York
Reporter: Barney Dixon

Mohawk tribe files to dismiss IPR


The Saint Regis Mohawk tribe has filed to dismiss an inter partes review (IPR) challenge from Mylan.

Allergan transferred its patents for its Restasis dry eye treatment to the tribe earlier this month, granting the patents immunity from IPR at the US Patent Trial and Appeal Board because Native American tribes hold sovereign immunity against any IPR challenges.

In its motion to dismiss the IPR review, filed on 22 September, the tribe said that the US Supreme Court had previously been asked to limit the scope of tribal immunity in the commercial context, but declined the do so and later reaffirmed the holding when asked to scale back tribal immunity on policy grounds.

The court stated that only Congress can “determine whether or how to limit tribal immunity”.

Allergan had previously said that its agreement with the tribe would have no impact on its patent litigation against the manufacturers of proposed generic versions of the drug.

Bob Bailey, chief legal officer at Allergan, explained that the tribe had come to it with a “sophisticated opportunity to strengthen the defense of our Restasis intellectual property in the upcoming IPR proceedings before the Patent Trial and Appeal Board”.

Bailey added: “Allergan evaluated this approach closely, with expert counsel in patent and sovereign immunity law … We are impressed with the Tribe's thoughtful and enterprising approach, which will allow them to achieve their goals of self-reliance and help them address the most urgent needs in their community."

The tribe said this was an important step towards diversifying its economic strategy and ensuring it remains self-reliant.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Patent perception must shift, says Schecter
13 December 2017 | London | Reporter: Barney Dixon
Public perception must shift if the US is to find feasible solutions to patent abuse, according to chief patent counsel at IBM Manny Schecter
Patent owners winning in IPR
12 December 2017 | New York | Reporter: Barney Dixon
Patent owners are winning more than losing in IPR proceedings, according to a study from law firm Fitzpatrick, Cella, Harper & Scinto
High tech companies weigh in on Allergan deal
11 December 2017 | Washington DC | Reporter: Barney Dixon
Tech companies have argued that Allergan should not be allowed to circumvent the inter partes review process with its controversial patent deal with the Saint Regis Mohawk Tribe
BlackBerry to pay $137 million to Nokia
08 December 2017 | Waterloo | Reporter: Barney Dixon
BlackBerry will pay $137 million to Nokia after the International Chamber of Commerce’s International Court of Arbitration ruled against the company in a patent licensing dispute
ILO ruling “vote of no confidence” for Battistelli, says CSC
07 December 2017 | Munich | Reporter: Barney Dixon
In an open letter to the EPO’s heads of delegations, the CSC said that it interpreted the ILO’s decision as a “massive vote of no confidence in the president of the EPO"
China world’s top patent filer in 2016
07 December 2017 | Geneva | Reporter: Barney Dixon
China has emerged as the top patent filer in the world, accounting for nearly all of the 8 percent growth in patent applications in 2016
EPO president’s impartiality questioned at ILO
06 December 2017 | Geneva | Reporter: Barney Dixon
The International Labour Organisation has questioned the impartiality of EPO president Benoît Battistelli, in two tribunal decisions concerning an EPO employee, and found that there was a conflict of interest on the part of the president